Your browser doesn't support javascript.
loading
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.
Bhatnagar, Sumit; Mukherjee, Dwaipayan; Salem, Ahmed Hamed; Miles, Dale; Menon, Rajeev M; Gibbs, John P.
Afiliação
  • Bhatnagar S; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA. sumit.bhatnagar@abbvie.com.
  • Mukherjee D; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA.
  • Salem AH; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA.
  • Miles D; Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
  • Menon RM; Clinical Pharmacology, Genentech Inc, South San Francisco, CA, USA.
  • Gibbs JP; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA.
Cancer Chemother Pharmacol ; 87(4): 465-474, 2021 04.
Article em En | MEDLINE | ID: mdl-33398386

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article